Exchange: NASDAQ·Updated 07:59 PM EDT

BTCY Biotricity Inc

$0.4399
$0.1829
(28.31%)
Today
Closed $0.4631
$0.0232
(5.01%)
After Hours
EarningsNov 12
Mkt Cap$1.7M
Vol532,001.00

About BTCY

Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. Its products include Bioflux, Biocore, Bioheart, Biokit, and Biocare. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on January 25, 2011 and is headquartered in Redwood City, CA.
50

Neutral Sentiment

How do you feel about BTCY?

StocktwitsNews
BTCY Q1 2027 Earnings Summary $BTCY https://stocktwits.com/news/earnings/ai summaries/btcy-q1-2027-earnings-summary/cZYKLwbRJnu
StocktwitsEarnings
$BTCY Q1 '27 Earnings Results & Recap Biotricity Inc. reported revenue of $4.3 million for the quarter ended June 30, 2026, representing a 10.4% year-over-year increase, driven by a 23.6% growth in recurring technology fee revenue.

Advertisement|Remove ads.